Clinical trial
I SELECT - Irbesartan In Hypertensive Patients With Left Ventricular Hypertrophy
NCT00362037 · Sanofi, Industry · Completed
Key facts
| NCT number | NCT00362037 |
|---|---|
| Title | I SELECT - Irbesartan In Hypertensive Patients With Left Ventricular Hypertrophy |
| Official title | Irbesartan In Hypertensive Patients With Left Ventricular Hypertrophy |
| Lead sponsor | Sanofi, Industry |
| Collaborators | Bristol-Myers Squibb Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Hypertension |
| Intervention type | Drug |
| Interventions | Irbesartan (Aprovel) |
| Enrollment | 281 |
| Start date | Mar 1, 2006 |
| Primary completion | Jun 1, 2008 |
| Completion | Jun 1, 2008 |
| First posted | Aug 9, 2006 |
| Last update posted | May 30, 2011 |
| Countries | Egypt |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: